Base Launch - Essential Agreements in Biotech Start-ups

Baselaunch, together with Vischer and Walder Wyss, is hosting an in-depth session on the essential legal agreements that shape the journey of a biotech start-up. While scientific progress and strategic planning are crucial to bringing a drug to market, a strong legal foundation is equally important. This event will walk participants through the key agreements that enable biotech companies to operate effectively from the earliest stages through growth and potential exit.

The program will cover the full spectrum of fundamental agreements, including shareholders’ agreements, research collaborations, licensing arrangements, financing documents such as convertible loans and investment agreements, cap table considerations, valuations, and M&A-related contracts. The speakers will also explore selected topics in greater detail based on participant input.

Experts from Walder Wyss, Robert von Rosen, Christoph Burckhardt and Simon Olstein, will share insights from their extensive experience advising life science companies.